Results

Total Results: 1,229 records

Showing results for "adverse event".
Users also searched for: patient safety indicators

81. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - Only one of the six studies (a nonrandomized study) found evidence of a benefit on any adverse event … effects (e.g., bleeding).6,7 The 2014 National Action Plan for Adverse Drug Event Prevention (ADE … event rates related to anticoagulation. … Advancing medication safety: establishing a national action plan for adverse drug event prevention. … Adverse event rates associated with oral anticoagulant treatment early versus later after hospital

82. Adverse Events Associated with COVID-19 Pharmaceutical Treatments | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/COVID-19-pharmaceutical-treatments/research

83. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
    September 01, 2009 - stroke (hemorrhagic, ischemic, or unspecified), transient ischemic attack, unspecified cerebrovascular event … one adverse event, elevated serum aspartate transaminase (AST) and/or alanine transaminase (ALT) above … Overall, 5 percent of participants had an event. … Compared with statin monotherapy, more participants developed at least one adverse event with statin-BAS … Nevertheless, all-cause mortality was a rare event across most trials. Followup duration.

84. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
    October 07, 2011 - In the studies that did report episodes of angioedema, this adverse event was observed only in patients … event data bases (E.G., the FDA AERs database) for information on angioedema. … Conceivably, information from adverse event databases would support the clinical impression that the … Aside from the risk itself, the emergence of a new adverse event from an outside meta-analysis raises … adverse event rates but no more benefit than a single drug.

85. Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
    January 01, 2023 - There may be no increase in risk of serious adverse events (strength of evidence [SOE]: low) or withdrawal … due to adverse events. … • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … Other prioritized adverse events (cannabis use disorder [CUD], psychosis, cognitive deficits) and the … event; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

86. Quantitative Synthesis II: Interactive Quiz (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
    May 29, 2025 - suited for testing hypotheses of whether one intervention is associated with a greater risk for an adverse … event than another and for quantifying that risk. … are well suited for testing hypotheses that one intervention is associated with a greater risk for an adverse … event than another and for quantifying that risk.

87. Quantitative Synthesis II: Interactive Quiz (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
    May 29, 2025 - suited for testing hypotheses of whether one intervention is associated with a greater risk for an adverse … event than another and for quantifying that risk. … are well suited for testing hypotheses that one intervention is associated with a greater risk for an adverse … event than another and for quantifying that risk.

88. Cer-250-Cannabis-2025-Surv-Rep-Update-Table-E5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-table-e5.xlsx
    January 01, 2025 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … event U.S.

89. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-computerized-cds-protocol.pdf
    May 08, 2023 - What is the frequency and severity of medication errors and adverse drug events? 2. … drug event after an encounter. … drug event rates o Medication error rates • Provider outcomes o Changes in prescribing behavior … Medication Errors and Adverse Drug Events. … Adverse drug events in ambulatory care.

90. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
    December 01, 2020 - Evidence is insufficient to draw conclusions about serious adverse events. … Evidence was insufficient to draw conclusions about serious adverse events. … Evidence was insufficient to draw conclusions about serious adverse events. … In general, adverse events of these drugs are mild and transient. … However, adverse events of newer medications require further study.

91. Management of Acute Diverticulitis Additional Information for Topic Nomination (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-nomination-extra.pdf
    May 29, 2025 - Resolution of diverticulitis, recurrent diverticulitis, avoidance of surgery, morbidity, mortality, adverse … events Diagnostic accuracy, adverse events Occult colorectal cancer, recurrent diverticulitis … , adverse events Resolution of diverticulitis, morbidity, mortality, adverse events Recurrent … diverticulitis, adverse events Timing All All Acute vs. convalescent All All Setting Inpatient,

92. Rheumatoid-Arthritis-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - Low Discontinuation rates and severe adverse events higher with infliximab. … Low No differences in adverse events in efficacy studies. … Low No differences in adverse events in efficacy studies. … Low No differences in adverse events in efficacy studies. … Low No differences in serious adverse events between groups.

93. Major-Depressive-Disorder Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
    December 01, 2015 - events, withdrawals because of adverse events, serious adverse events, specific adverse events (including … because of adverse events. … of adverse events. … events, overall risk of serious adverse events, or discontinuation due to adverse events. … event rates for acupuncture than SGAs.

94. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
    August 01, 2016 - Clinical Event Outcomes, RCTs No RCTs reported clinical event outcomes for comparisons of total n-3 … Clinical Event Outcomes, RCTs Regarding clinical event outcomes, one trial in an at risk population … Clinical Event Outcomes, RCTs No trial that reported clinical event outcomes evaluated DHA alone. … Clinical Event Outcomes, RCTs No trial that reported clinical event outcomes compared marine oil FA … study arms, and no serious or severe adverse event was attributed to n-3 FA.

95. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
    May 07, 2010 - event rates, overall adverse event rates, and withdrawals due to adverse events, withdrawal rates, … events •Withdrawals due to adverse events •Serious adverse events reported •Withdrawal rates •Switch … Also, adverse events (including, but not limited to, weight gain, impaired renal function, angioedema … events, withdrawals due to adverse events, serious adverse events reported, withdrawal rates, switch … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

96. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - Also, ACEIs are associated with well-known adverse events not shared by ARBs, including cough (estimated … events, withdrawals due to adverse events, serious adverse events reported, withdrawal rates, and switch … This may reflect low event rates among otherwise healthy patients and relatively few studies with extended … For RCTs, this translates to a difference in rates safety, adverse events, tolerability, to Moderate … There was no evidence of differences in rates of other commonly reported specific adverse events.

97. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
    July 01, 2023 - Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy … In addition to being a serious adverse event, mucositis also facilitates entry of oral bacteria into … However, it is a serious adverse event occurring in some cancer patients, and early dental evaluation … event rates in patients with cancer. … event rates and other relevant outcomes?

98. high-cholesterol-medicines-update-protocol-130516 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
    December 31, 2013 - adherence as defined by the study investigator  SAEs as defined by the study investigator (e.g., an event … event; withdrawal due to an adverse event; cancer; serum aspartate transaminase and/or alanine aminotransferase … event; withdrawal due to an adverse event; cancer; serum AST and/or serum ALT elevated ≥ 3 times … For sparse-data meta-analysis, we will employ the Peto odds ratio method when event rates are less than … When between-event rates are between 5 to 10 percent, substantial differences between the N of two arms

99. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
    September 01, 2011 - In children with JIA, do the rate and type of adverse events differ between: a. … comparisons of the rate and type of adverse events among the various DMARDs. … Recently published studies of adverse event reporting databases provide indirect evidence that suggests … • Reporting of adverse events. … A review of other study designs revealed marked differences in the rate and type of adverse event by

100. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - • In THR, LMWH has lower VTE and adverse event risks than unfractionated heparin; LMWH and aspirin … One NRCS had high risk of bias for adverse event reporting and one was unclear. … Only about half of studies reported major bleeding, the adverse event of greatest concern for most … For VTE prophylaxis studies, there is a fairly standard list of VTE and adverse event outcomes that … Larger RCTs should evaluate differences in treatment and adverse event effects in relevant subgroups